Stock Ticker

  • Loading stock data...

Johnson & Johnson (NYSE:JNJ) Enrols 45,000 Subjects in the Study of Its Experimental COVID-19 Vaccine Candidate

Johnson & Johnson (NYSE:JNJ) has said that it enrolled around 45,000 participants for its late stage study of its single-dose COVID-19 vaccine candidate and anticipates interim data at the end of January 2021. ENSEMBLE Study enrolls 45,000 participants The pharmaceutical company seems to lag rivals such as Moderna Inc. (NASDAQ:MRNA) and Pfizer Inc. (NYSE:PFE) in […]

Merck (NYSE:MERK) Quits RSV Vaccine Development With Moderna (NASDAQ:MRNA), But Will Continue Oncology Collaboration

Merck & Co Inc. (NYSE:MERK) is returning all rights to the respiratory syncytial virus (RSV) vaccine to Moderna Inc. (NASDAQ:MRNA) barely after helping take the vaccine into the clinic. The vaccine dubbed mRNA-1172 used Merck’s lipid nanoparticle delivery. Merck to hand over RSV rights to Moderna The pharmaceutical company is doubling down on its in-house […]

Moderna Inc (NASDAQ:MRNA) Triggers Hype In Wall Street After Coronavirus Vaccine Announcement But Critics Cry Faul

Moderna Inc (NASDAQ:MRNA) recently revealed that the preliminary results of its coronavirus vaccine trial have yielded positive results leading to a surge in its stock price, but the announcement also yielded some criticism. The U.S-based biotech revealed that the initial results of its coronavirus vaccine were promising. This was enough to encourage positive sentiments regarding […]

Moderna Inc. (NASDAQ:MRNA) Releases Positive Data For Its Coronavirus Vaccine Candidate In Human Trials

Moderna Inc. (NASDAQ:MRNA) has released positive data from its first human trials for its COVID-19 vaccine candidate, demonstrating that the healthy volunteers who received the vaccine developed antibody responses. Moderna’s vaccine in humans shows positive immunity response The company which had partnered with the National Institute of Health in developing the vaccine indicated that there […]